Long-term efficacy of up to 15 months' efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasis.

Saved in:
Bibliographic Details
Title: Long-term efficacy of up to 15 months' efalizumab therapy in patients with moderate-to-severe chronic plaque psoriasis.
Authors: Toth DP; Probity Medical Research, Kitchener Ontario, Canada. drtoth@bellnet.ca, Papp K, Gratton D
Source: Dermatologic therapy [Dermatol Ther] 2008 Nov-Dec; Vol. 21 Suppl 3, pp. S6-14.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print Cited Medium: Internet ISSN: 1529-8019 (Electronic) Linking ISSN: 13960296 NLM ISO Abbreviation: Dermatol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1529-8019
DOI:10.1111/j.1529-8019.2008.00235.x